top of page

Post-Budget Summit

BPD Annual Conference 2024

'A second day and an expanded focus'

The annual event will occur after the 2024-25 Budget incorporates a second day. The agenda for day one will maintain its traditional focus on policy issues impacting the sector. The agenda for day two will be constructed for people interested in a discussion about the commercial issues impacting the sector. People can register for one or both days.

20 and 21 May 2024
Sydney, Australia
Four Seasons, Grand Ballroom

The half-day summit will discuss the implications of the Labor federal government's first Budget and the progress of other policy initiatives, including the National Medicines Policy and health technology assessment reviews.

About

About The Event.

Monday, 20 May

 

Day one of the annual BioPharmaDispatch conference provides a full-day opportunity to discuss the federal government's 2024-25 Budget and other related issues.

The event occurs at a critical time, with the 2024-25 Budget, a new Community Pharmacy Agreement, and the outcomes of multiple review processes.

Day two - Tuesday, 21 May

A forward-looking agenda for people with an interest in how the sector is evolving to manage contemporary challenges.

 

The conference program will be built to provide an engaging, informed and wide-ranging discussion on these and other related issues with the goal to ensure an open dialogue involving patients.

Complimentary registration will be available for patients and their representatives - email contact@dailydispatch.com.au for more information.

+500

+20

Participants
Sessions

Speakers.

Speakers

At Clarivate Life Sciences and Healthcare, our goal is to empower our customers to create a healthier tomorrow. We provide data, deep expertise and intelligence platforms to enable our customers to deliver safe, effective and commercially successful treatments / solutions to patients faster. Through transformative intelligence, we empower our clients to anticipate and address healthcare’s biggest challenges in an ever-evolving world. All with the most important person in mind—the patient. Please check our website to know more about our solutions.

Agenda

Indicative Conference Program.

The program is close to final but also indicative. We expect to add more speakers and potentially sessions
Monday, 20 May

 

Day one of the annual BioPharmaDispatch conference provides a full-day opportunity to discuss the federal government's 2024-25 Budget and other related issues

8.50am - 9.00am
Welcome and introduction
 
9.00am - 9.45am
Two leading advocates, Painaustralia's Giulia Jones and Arthritis Australia's Jonathon Smithers, frame the first day with a patient-focused discussion (Rachel Smalley moderator)
9.45am - 10.30am
 
Reflections of the outgoing PBAC chair Professor Andrew Wilson AO
10.30am -11.00am - Break
11.00am - 12.00pm
Keynote address - Senator The Hon Anne Ruston, Shadow Minister for Health and Aged Care
12.00pm - 12.45pm
Progress in New Zealand and the lessons? The first part of a discussion involving journalist and advocate Rachel Smalley, patient and advocate Fiona Tolich, Todd Stephenson MP, and Medicines NZ chief executive Dr Graeme Jarvis
12.45pm - 1.45pm - Lunch
1.45pm - 2.45pm
What now in New Zealand? The second part of a discussion involving journalist and advocate Rachel Smalley, Tatient and advocate Fiona Tolich, Todd Stephenson MP, and Medicines NZ chief executive Dr Graeme Jarvis
2.45pm - 3.30pm
Pharmacy Guild National President, Professor Trent Twomey - Update on 8CPA
3.30pm - 4.00pm - Break
4.00pm - 4.45pm
What now after the' chemotherapy review' with ICON Group leader David Slade and SHPA president Tom Simpson
4.45pm - 5.30pm
Reflections from industry leaders - Novartis' Matt Zeller, BioMarin's Dr Kathryn Evans, Edwards Lifesciences Pat Williams, Viatris' Sylvain Vigneault
5.30pm - 7.00pm - Reception
Tuesday, 21 May

 

Day two of the annual BioPharmaDispatch conference provides a full-day focus on the way forward for stakeholders with an interest in patient access to new health technologies

9.00am - 9.30am
Welcome and introduction - the BPD perspective on day one
9.30am - 10.00am
Rare Cancers Australia chief executive Christine Cockburn shares her ambitions for the organisation
10.00am - 11.00am
Keynote address - Dr Ian Watt AC, former secretary of the Department of the Prime Minister and Cabinet, on the future of reform in an era of fiscal consolidation
11.00am - 11.30am - Break
11.30am - 12.00pm
Medicines Australia chief executive Liz de Somer
12.00pm - 12.30pm
The future of biosimilars and options for reform with Arrotex's Hayley Tamborini and Sandoz's Clint Holland
12.30pm -1.00pm
Government and stakeholder engagement against the backdrop of the HTA Review and ahead of the next federal election and beyond with Gilead's Belinda Wood, Edwards Lifesciences Polo Guilbert Wright, Abbott's Paul Davies, and AstraZeneca's Penny George
1.00pm - 2.00pm - Lunch
2.00pm - 3.00pm
How to fix the inequity in women's health with Organon's Sam Howes, Bayer's Sarah Bridge, and Professor Deb Bateson AM
3.00pm - 3.45pm
 
Boehringer Ingelheim's Dirk Otto
3.45pm - 4.30pm
 
Bristol Myers Squibb's Owen Smith
Register

Register.

Register for the BPD Annual Conference 2024

Location
bottom of page